No Data
Minsheng Securities: The advantages of CGM real-time blood glucose monitoring are significant, with outstanding clinical value.
Driven by factors such as the deepening global aging population, the increasing demand for the diagnosis and treatment of diabetes patients, and the gradual improvement of the healthcare insurance system, the CGM industry will experience continuous growth.
Returns On Capital At Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Have Stalled
The Market Doesn't Like What It Sees From Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.'s (SZSE:002223) Earnings Yet
ZY Electronics' IPO has been terminated. The products have entered the supply chain systems of customers such as BYD Company Limited, contemporary amperex technology, etc.
On November 7th, Guangzhou Zhiyuan Electronics Co., Ltd. (referred to as Zhiyuan Electronics) terminated its GEM IPO on the Shenzhen Stock Exchange. This was due to Zhiyuan Electronics and the sponsor withdrawing their application for listing. In accordance with the 62nd article of the Shenzhen Stock Exchange's Stock Issuance and Listing Review Rules (Revised in 2024), the Shenzhen Stock Exchange decided to terminate the review of its listing application.
Sinolink Securities: The advantage of "price + medical insurance" brings a breakthrough in CGM volume. Focus on the expansion of medical instruments in the European and American markets.
Europe and the United States occupy more than two-thirds of the global CGM market share, and the average selling price of CGM products is significantly higher compared to domestic prices. If domestic companies can expand overseas markets, they will unlock greater demand and higher price levels.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Do Jiangsu Yuyue Medical Equipment & Supply's (SZSE:002223) Earnings Warrant Your Attention?
